Public hearing - Thursday, 28 March 2013

Supply of chemotherapy drugs such as Docetaxel

Public hearing - Thursday, 28 March 2013

Time: 11.15 am – 4.15 pm

Venue: Room 12+13, Cliftons
60 Margaret Street
Sydney

11.15am - 11.45am

Cancer Voices Australia (Submission 18)

11.45 am - 12.45 pm

Pharmacy Guild of Australia (Submission 25)
Mr Stephen Armstrong
Clinical Oncology Society of Australia
(Submission 16)
Mr Dan Mellor - Chair of the COSA Cancer Pharmacists Group
Northern Cancer Institute (Submission 7)
Mr Tony Noun - Executive Chairman

12.45 pm - 1.30 pm

Society of Hospital Pharmacists in Australia
(Submission 6)
Mrs Suzanne Kirsa - President
Mrs Helen Dowling - Chief Executive Officer
Slade Pharmacy Services (Submission 9)
Mr David Slade - Managing Director
Mr Wayne Pertzel
APHS Pharmacy Group (Submission 31)
Mr Stuart Giles - Managing Partner and Executive Chairman

1.30 pm - 2.00 pm

Lunch

2.00 pm - 2.45 pm

Department of Health and Ageing
Mr David Learmonth - Deputy Secretary
Ms Felicity McNeill - First Assistant Secretary, Pharmaceutical Benefits Division

2.45 pm - 3.15 pm

Consumers Health Forum of Australia
(via teleconference)
(Submission 22)
Ms Carol Bennett - Chief Executive Officer

3.15 pm - 4.00 pm

Integrated Clinical Oncology Network Cancer Care Board (Submission 19)
Dr Brett Robinson - Managing Director and Chief Executive Officer
Private Cancer Physicians of Australia and Medical Oncology Group Australia (Submission 17)
Dr John Bashford
Sydney Adventist Hospital - Pharmacy Services (Submission 15)
Dr Leon Clark - Chief Executive Officer
Mrs Margaret Duffy - Pharmacy/Corporate Services Executive Officer

4.00pm - 4.15pm

CanSpeak (Submission 14)

4.15 pm

Adjournment

For further information, contact:

Committee Secretary
Senate Community Affairs References Committee
PO Box 6100
Parliament House
Canberra ACT 2600
Australia

Phone: +61 2 6277 3518
Fax: +61 2 6277 5829
Email: community.affairs.sen@aph.gov.au